NCT00602784View on ClinicalTrials.gov

Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

May 31, 2004

Study Completion Date

September 30, 2004

Conditions
Chronic Hepatitis C
Interventions
BIOLOGICAL

IC41

All Listed Sponsors
lead

Valneva Austria GmbH

INDUSTRY

NCT00602784 - Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine | Biotech Hunter | Biotech Hunter